Abstract:Background:New clinically important postoperative atrial fibrillation (POAF) is the most common arrhythmia after thoracoscopic anatomical lung cancer surgery and is associated with increased morbidity and mortality. The full spectrum of predictors remains unclear, and effective assessment tools are lacking. This study aimed to develop and externally validate a novel model for predicting new clinically important POAF.Methods:This retrospective study included 14 074 consecutive patients who received thoracoscopic anatomical lung cancer surgery from January 2016 to December 2018 in Shanghai Chest Hospital. Based on the split date of 1 January 2018, we selected 8717 participants for the training cohort and 5357 participants for the testing cohort. For external validation, we pooled 2941 consecutive patients who received this surgical treatment from July 2016 to July 2021 in Shanghai Ruijin Hospital. Independent predictors were used to develop a model and internally validated using a bootstrap-resampling approach. The area under the receiver operating characteristic curves (AUROCs) and Brier score were performed to assess the model discrimination and calibration. The decision curve analysis (DCA) was used to evaluate clinical validity and net benefit. New clinically important POAF was defined as a new-onset of POAF that causes symptoms or requires treatment.Results:Multivariate analysis suggested that age, hypertension, preoperative treatment, clinical tumor stage, intraoperative arrhythmia and transfusion, and operative time were independent predictors of new clinically important POAF. These seven candidate predictors were used to develop a nomogram, which showed a concordance statistic (C-statistic) value of 0.740 and good calibration (Brier score; 0.025). Internal validation revealed similarly good discrimination (C-statistic, 0.736; 95% CI: 0.705-0.768) and calibration. The decision curve analysis showed positive net benefits with the threshold risk range of 0-100%. C-statistic value and Brier score were 0.717 and 0.028 in the testing cohort, and 0.768 and 0.012 in the external validation cohort, respectively.Conclusions:This study identified seven predictors of new clinically important POAF, among which preoperative treatment, intraoperative arrhythmia, and operative time were rarely reported. The established and externally validated model has good performance and clinical usefulness, which may promote the application of prevention and treatment in high-risk patients, and reduce the development and related adverse outcomes of this event.

Differential Expression of Mrna in Peripheral Blood Mononuclear Cells May Predict Postoperative Atrial Fibrillation in Coronary Artery Bypass Surgery Patients

Investigation of the Underlying Hub Genes and Mechanisms of Reperfusion Injury in Patients Undergoing Coronary Artery Bypass Graft Surgery by Integrated Bioinformatic Analyses.

Preoperative Plasma Biomarkers Associated with Atrial Fibrillation after Coronary Artery Bypass Surgery

MicroRNA signature predicts post-operative atrial fibrillation after coronary artery bypass grafting

Increased IL-12p70 Levels in Intraoperative Pericardial Fluid Are Predictive of Postoperative Atrial Fibrillation Onset after Coronary Artery Bypass Surgery

Metabolic Signatures in Pericardial Fluid and Serum Are Associated with New-Onset Atrial Fibrillation after Isolated Coronary Artery Bypass Grafting

Potentially Risk Factors for New Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Grafting: A Retrospective Cohort Study

Th17/Treg Ratio in Serum Predicts Onset of Postoperative Atrial Fibrillation after Off-Pump Coronary Artery Bypass Graft Surgery.

RETRACTED: Changed Expression of Micrornas May Predict Postoperative Atrial Fibrillation in Patients with Cardiac Surgery (retracted Article. See Vol. 25, Pg. 3400, 2021)

High mobility group box 1 gene polymorphism is associated with the risk of postoperative atrial fibrillation after coronary artery bypass surgery

Exploring anesthetic-induced gene expression changes and immune cell dynamics in atrial tissue post-coronary artery bypass graft surgery

Predictive value of miR-636 in patients with acute myocardial infarction undergoing percutaneous coronary intervention and its bioinformatics analysis

Relationship between serum microRNA-146a, microRNA-499 and new onset atrial fibrillation after off-pump coronary artery bypass grafting in patients with coronary heart disease

NEURL Rs6584555 and CAND2 Rs4642101 Contribute to Postoperative Atrial Fibrillation: a Prospective Study among Chinese Population.

Analysis of infiltrated immune cells in left atriums from patients with atrial fibrillation and identification of circRNA biomarkers for postoperative atrial fibrillation

Integration of Gene Expression Profile Data of Human Epicardial Adipose Tissue From Postoperative Atrial Fibrillation to Verification of Hub Genes

Development and External Validation of a Novel Model for Predicting New Clinically Important Atrial Fibrillation after Thoracoscopic Anatomical Lung Cancer Surgery: a Multicenter Retrospective Cohort Study.

Identification and Verification of FN1, P4HA1 and CREBBP As Potential Biomarkers in Human Atrial Fibrillation

Identification of Anesthetic-Induced Cardiovascular Biomarkers in Off-Pump Coronary Artery Bypass Grafting Surgery Using Weighted Gene Co-Expression Network Analysis and Machine Learning

Risk Factors of Postoperative Atrial Fibrillation After Isolated Coronary Artery Bypass Grafting Surgery in the Recent 10 Years: Clinical Analysis of 6229 Patients

Haematological indices as predictors of atrial fibrillation following isolated coronary artery bypass grafting, valvular surgery, or combined procedures: a systematic review with meta-analysis.